APA (7th ed.) Citation

Timmerman, J., Herbaux, C., Ribrag, V., Zelenetz, A. D., Houot, R., Neelapu, S. S., . . . Levy, R. (2020). Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma. American journal of hematology, 95(5), 510-520. https://doi.org/10.1002/ajh.25757

Chicago Style (17th ed.) Citation

Timmerman, John, et al. "Urelumab Alone or in Combination with Rituximab in Patients with Relapsed or Refractory B‐cell Lymphoma." American Journal of Hematology 95, no. 5 (2020): 510-520. https://doi.org/10.1002/ajh.25757.

MLA (9th ed.) Citation

Timmerman, John, et al. "Urelumab Alone or in Combination with Rituximab in Patients with Relapsed or Refractory B‐cell Lymphoma." American Journal of Hematology, vol. 95, no. 5, 2020, pp. 510-520, https://doi.org/10.1002/ajh.25757.